RADCQ Loading...

From CVS earnings calls
Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
13:00
Feb 10 ◎
Brian Newman CFO, CVS Health Corporation CVS Q4 FY25 call
CVS's 2025 results benefited from the Rite Aid asset acquisition, boosting prescription volume and store count, continuing to reshape the retail pharmacy landscape.
RADCQ
HIGH

About RADCQ Analyst Coverage

Buzzberg tracks RADCQ across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade idea tracked. Latest voices: Brian Newman.